Taxotere: Clinical trials in non-small cell lung cancer

Oncologist

Volumn 3, Issue 2, 1998, Pages 86-93

  Ornstein, Deborah L ^b   Rigas, James R ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b NONE

Author keywords

Docetaxel; Non small cell lung cancer; Phase II trials

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; IRINOTECAN; NAVELBINE; VINDESINE;

ADVANCED CANCER; ALOPECIA; ARTICLE; ASTHENIA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DRUG HYPERSENSITIVITY; ESOPHAGITIS; FEMALE; FLUID RETENTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; ONYCHOLYSIS; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENT CANCER; SENSORY NEUROPATHY; VOMITING;

EID: 0031900917     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.3-2-86     Document Type: Article

References (11)

1. Parker SL, Tong T, Bolden S et al. Cancer statistics, 1997. CA: A Cancer Journal for Clinicians 1997;47:5-27.
2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group (Comments). Br Med J 1995;311:899-909.
3. Cullen MH, Woodroffe CM, Billingham LJ et al. Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 2. Results of a randomised trial in patients with extensive disease. Lung Cancer 1997;18:5a.
4. Gueritte-Voegelein F, Guenard D, Lavelle F et al. Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem 1991;34:992-998.
5. Ringel I, Horwitz SB. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 1991;83:288-291.
6. Diaz JF, Andreu JM. Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition. Biochemistry 1993;32:2747-2755.
7. Von Hoff DD. The taxoids: same roots, different drugs. Semin Oncol 1997;24(suppl 13):10-13.
8. Bruno R, Sanderink GJ. Pharmacokinetics and metabolism of Taxotere (docetaxel). Cancer Surv 1993;17:305-313.
9. Dorr RT. Pharmacology of the taxanes. Pharmacotherapy 1997;17:96S-104S.
10. Lavelle F, Bissery MC, Combeau C et al. Preclinical evaluation of docetaxel (Taxotere). Semin Oncol 1995;22(suppl 4):3-16.
11. Vogel M, Hilsenbeck SG, Depenbrock H et al. Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: comparison with taxol and conventional antineoplastic agents. Eur J Cancer 1993;29A:2009-2014.